MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1

被引:0
作者
Yupeng Ren
Hao Zhang
Peng Jiang
机构
[1] Liaoning Cancer Hospital & Institute,Department of Colorectal Surgery, Cancer Hospital of China Medical University
来源
Biological Research | / 51卷
关键词
-; SP1; Colorectal cancer; Tumor progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 166 条
[1]  
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]  
Bray F(2017)Colorectal cancer statistics, 2017 CA Cancer J Clin 67 177-193
[3]  
Siegel RL(2010)Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 544-573
[4]  
Ferlay J(2015)An updated Asia Pacific Consensus Recommendations on colorectal cancer screening Gut. 64 121-132
[5]  
Lortet-Tieulent J(2015)SP1 and the “hallmarks of cancer” FEBS J 282 224-258
[6]  
Jemal A(1998)Distinct regions of SP1 modulate DNA binding and transcriptional activation Science 242 1566-1570
[7]  
Siegel RL(2018)Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer BMC Cancer. 18 367-2684
[8]  
Miller KD(2017)SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model Oncol Rep 38 2677-7
[9]  
Fedewa SA(2012)SP1 is involved in regulation of cystathionine gamma-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines Cell Signal 24 1229240-314
[10]  
Ahnen DJ(2017)Specificity protein 1: its role in colorectal cancer progression and metastasis Crit Rev Oncol Hematol 113 1-8156